MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pulmonary Hypertension Research and Treatments
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,304 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,304 works in the cohort · of 4,299,418page 5 of 47

Labels cover 4 of 2,304 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,304 of 2,304 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affvenueunlabeled
The endothelin system in pulmonary hypertension
René P. Michel, David Langleben, Jocelyn Dupuis
2003· review· en· Canadian Journal of Physiology and Pharmacology· Medicine
machine prediction:candidate · noneconsensus · none
95
citations
fundno affunlabeled
Risk assessment in pulmonary arterial hypertension
Marius M. Hoeper, David Pittrow, Christian Opitz, J. Simon R. Gibbs, Stephan Rosenkranz, Ekkehard Grünig +2 more
2018· letter· en· European Respiratory Journal· Medicine
machine prediction:candidate · noneconsensus · none
92
citations
affno abstractunlabeled
PATHOBIOLOGY OF PULMONARY HYPERTENSION
Marlene Rabinovitch
2001· review· en· Clinics in Chest Medicine· Medicine
machine prediction:candidate · noneconsensus · none
89
citations
affunlabeled
Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
Mélanie Lambert, Véronique Capuano, Andrea Olschewski, Jessica Sabourin, Chandran Nagaraj, Barbara Girerd +3 more
2018· review· en· International Journal of Molecular Sciences· Medicine
machine prediction:candidate · noneconsensus · none
86
citations
aboutno affunlabeled
Bosentan: a dual endothelin receptor antagonist
Sébastiên Roux, Lewis J. Rubin
2002· review· en· Expert Opinion on Investigational Drugs· Medicine
machine prediction:candidate · noneconsensus · none
82
citations
affunlabeled
Potassium channels in pulmonary arterial hypertension
Olivier Boucherat, Sophie Chabot, Fabrice Antigny, Frédéric Perros, Steeve Provencher, Sébastien Bonnet
2015· review· en· European Respiratory Journal· Medicine
machine prediction:candidate · noneconsensus · none
81
citations

How this was built: Screen · Findings · About